Aegis Affirms Progenics Pharma (PGNX) at 'Buy'; Solid Relistor Results Fuel Q3 Revenue Gains (VRX)
Go back to Aegis Affirms Progenics Pharma (PGNX) at 'Buy'; Solid Relistor Results Fuel Q3 Revenue Gains (VRX)| Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) | Delayed: 4.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.10 | 52 Week High | $7.75 | |||
| Open | $111.64 | 52 Week Low | $3.61 | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $4.10 | EPS | $-0.62 | |||
| Volume | 6,812 | |||||
| VALEANT PHARMACEUTICALS INTERNATIONAL (NYSE: VRX) | Delayed: 23.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.40 | 52 Week High | $119.86 | |||
| Open | $23.40 | 52 Week Low | $13.77 | |||
| Day High | $23.40 | P/E | N/A | |||
| Day Low | $23.40 | EPS | $0.00 | |||
| Volume | 378,733 | |||||
